26th September
The Cat is Out of the Bag!! Learn about the latest feline HCM research from scientists, researchers and cat owners. Viewpoint with Dennis Quaid and TriviumVet have teamed up to...
TriviumVet:
TriviumVet launch the HALT HCM Study recruiting 300 cats with diagnosed subclinical Hypertrophic Cardiomyopathy (HCM)
25th June
We at TriviumVet are thrilled to announce that the long-awaited HALT HCM Study is now live and recruiting cats in cardiac care centers across the United States! The study was...
TriviumVet's Chief Scientific Officer, Dr. Stuart Fitzgerald appointed to NC State Industry Advisory Council
17th November
We are delighted to congratulate our Chief Scientific Officer, Dr. Stuart Fitzgerald on his appointment to this exciting new advisory council through which he will help to shape...
TriviumVet's Feline Chronic Kidney Disease (CKD) candidate deemed eligible for the Expanded Conditional Approval Pathway by the FDA!
10th October
FDA’s Centre for Veterinary Medicine deems TriviumVet’s feline Chronic Kidney Disease (CKD) therapeutic candidate eligible for the Expanded Conditional Approval pathway
TriviumVet are exhibiting at AAFP 2023!!
6th October
We are delighted to announce that we will be exhibiting at the American Association of Feline Practitioners conference 2023 taking place in Memphis, Tennessee next weekend. This...
Viewpoint With Dennis Quaid
26th September
The Cat is Out of the Bag!! Learn about the latest feline HCM research from scientists, researchers and cat owners. Viewpoint with Dennis Quaid and TriviumVet have teamed up to...
Feline HCM product prevented progression of hypertrophy - Results of the RapaCat Study published in JAVMA
28th July
TriviumVet are proud to announce the publication of the results of the RapaCat Study in the Journal of the American Veterinary Medical Association. This study used our novel,...
S&P Global Animal Health Interview TriviumVet CEO Louise Grubb on upcoming product authorizations
28th July
S&P Global Animal Health Interview TriviumVet CEO Louise Grubb on upcoming product authorizations You can read the full article below....
Congratulations to NC State’s Olby as she Wins 2023 AVMA Career Achievement in Canine Research Award
18th July
Dr. Olby, is a professor of veterinary neurology and neurosurgery at the North Carolina Veterinary School, she has authored or co-authored more than 200 scientific papers, most...
Cutting edge Feline Hypertrophic Cardiomyopathy Research to be presented to the American College of Veterinary Internal Medicine (ACVIM)
20th April
Two exciting pieces of feline hypertrophic cardiomyopathy (HCM) research are to be presented to the American College of Veterinary Internal Medicine (ACVIM) this year on their...
TriviumVet CEO Louise Grubb wins IMAGE PwC Business Woman of the Year 2023 Award
17th April
Serial entrepreneur Louise Grubb, founder and CEO of the game-changing companion animal diagnosis and treatment business TriviumVet, was awarded the overall title of Businesswoman...
TriviumVet:
TriviumVet's Chief Scientific Officer, Dr. Stuart Fitzgerald appointed to NC State Industry Advisory Council
17th November
We are delighted to congratulate our Chief Scientific Officer, Dr. Stuart Fitzgerald on his appointment to this exciting new advisory council through which he will help to shape...
TriviumVet's Feline Chronic Kidney Disease (CKD) candidate deemed eligible for the Expanded Conditional Approval Pathway by the FDA!
10th October
FDA’s Centre for Veterinary Medicine deems TriviumVet’s feline Chronic Kidney Disease (CKD) therapeutic candidate eligible for the Expanded Conditional Approval pathway
TriviumVet are exhibiting at AAFP 2023!!
6th October
We are delighted to announce that we will be exhibiting at the American Association of Feline Practitioners conference 2023 taking place in Memphis, Tennessee next weekend. This...
Viewpoint With Dennis Quaid
26th September
The Cat is Out of the Bag!! Learn about the latest feline HCM research from scientists, researchers and cat owners. Viewpoint with Dennis Quaid and TriviumVet have teamed up to...
Feline HCM product prevented progression of hypertrophy - Results of the RapaCat Study published in JAVMA
28th July
TriviumVet are proud to announce the publication of the results of the RapaCat Study in the Journal of the American Veterinary Medical Association. This study used our novel,...
S&P Global Animal Health Interview TriviumVet CEO Louise Grubb on upcoming product authorizations
28th July
S&P Global Animal Health Interview TriviumVet CEO Louise Grubb on upcoming product authorizations You can read the full article below....
Congratulations to NC State’s Olby as she Wins 2023 AVMA Career Achievement in Canine Research Award
18th July
Dr. Olby, is a professor of veterinary neurology and neurosurgery at the North Carolina Veterinary School, she has authored or co-authored more than 200 scientific papers, most...
Cutting edge Feline Hypertrophic Cardiomyopathy Research to be presented to the American College of Veterinary Internal Medicine (ACVIM)
20th April
Two exciting pieces of feline hypertrophic cardiomyopathy (HCM) research are to be presented to the American College of Veterinary Internal Medicine (ACVIM) this year on their...
TriviumVet CEO Louise Grubb wins IMAGE PwC Business Woman of the Year 2023 Award
17th April
Serial entrepreneur Louise Grubb, founder and CEO of the game-changing companion animal diagnosis and treatment business TriviumVet, was awarded the overall title of Businesswoman...